Theobald Sebastian J, Gräb Jessica, Fritsch Melanie, Suárez Isabelle, Eisfeld Hannah S, Winter Sandra, Koch Maximilian, Hölscher Christoph, Pasparakis Manolis, Kashkar Hamid, Rybniker Jan
Department I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
Cell Death Discov. 2021 Oct 30;7(1):327. doi: 10.1038/s41420-021-00716-5.
Necrotic cell death represents a major pathogenic mechanism of Mycobacterium tuberculosis (Mtb) infection. It is increasingly evident that Mtb induces several types of regulated necrosis but how these are interconnected and linked to the release of pro-inflammatory cytokines remains unknown. Exploiting a clinical cohort of tuberculosis patients, we show here that the number and size of necrotic lesions correlates with IL-1β plasma levels as a strong indicator of inflammasome activation. Our mechanistic studies reveal that Mtb triggers mitochondrial permeability transition (mPT) and subsequently extensive macrophage necrosis, which requires activation of the NLRP3 inflammasome. NLRP3-driven mitochondrial damage is dependent on proteolytic activation of the pore-forming effector protein gasdermin D (GSDMD), which links two distinct cell death machineries. Intriguingly, GSDMD, but not the membranolytic mycobacterial ESX-1 secretion system, is dispensable for IL-1β secretion from Mtb-infected macrophages. Thus, our study dissects a novel mechanism of pathogen-induced regulated necrosis by identifying mitochondria as central regulatory hubs capable of delineating cytokine secretion and lytic cell death.
坏死性细胞死亡是结核分枝杆菌(Mtb)感染的主要致病机制。越来越明显的是,Mtb可诱导多种类型的程序性坏死,但这些坏死之间如何相互关联以及与促炎细胞因子的释放有何联系仍不清楚。利用一组肺结核患者的临床队列,我们在此表明坏死病灶的数量和大小与IL-1β血浆水平相关,而IL-1β血浆水平是炎性小体激活的有力指标。我们的机制研究表明,Mtb触发线粒体通透性转换(mPT),随后导致广泛的巨噬细胞坏死,这需要NLRP3炎性小体的激活。NLRP3驱动的线粒体损伤依赖于成孔效应蛋白gasdermin D(GSDMD)的蛋白水解激活,GSDMD将两种不同的细胞死亡机制联系起来。有趣的是,GSDMD而非具有膜溶解作用的分枝杆菌ESX-1分泌系统对于Mtb感染的巨噬细胞分泌IL-1β是可有可无的。因此,我们的研究通过将线粒体确定为能够描绘细胞因子分泌和溶解性细胞死亡的中心调节枢纽,剖析了病原体诱导的程序性坏死的新机制。